Tumor cells with intact or upregulated IFN signaling are able to mount robust antiviral responses, often through activation of the JAK/STAT pathway and induction of interferon-stimulated genes (ISGs), which restrict viral replication and oncolysis (201). This evidence concerns the gene SOAT1 and neoplasm.